These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20404640)

  • 1. Importance of levosimendan on right ventricular function in patients with biventricular heart failure.
    Erdem A; Birhan Yilmaz M
    Crit Care Med; 2010 May; 38(5):1389-90; author reply 1390-1. PubMed ID: 20404640
    [No Abstract]   [Full Text] [Related]  

  • 2. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
    Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
    Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do it right?
    Delle Karth G; Heinz G
    Crit Care Med; 2009 Dec; 37(12):3168-9. PubMed ID: 19923936
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
    Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levosimendan in cardiogenic shock: the magic drug for every patient?
    Smetana P; Geppert A
    Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
    [No Abstract]   [Full Text] [Related]  

  • 6. Levosimendan: right for the right ventricle?
    Lambermont B; Ghuysen A; Harstein G; D'Orio V
    Crit Care Med; 2007 Aug; 35(8):1995-6. PubMed ID: 17667254
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of levosimendan on right ventricular function and ventriculovascular coupling in open chest pigs.
    Leather HA; Ver Eycken K; Segers P; Herijgers P; Vandermeersch E; Wouters PF
    Crit Care Med; 2003 Sep; 31(9):2339-43. PubMed ID: 14501965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
    Russ MA; Prondzinsky R; Christoph A; Schlitt A; Buerke U; Söffker G; Lemm H; Swyter M; Wegener N; Winkler M; Carter JM; Reith S; Werdan K; Buerke M
    Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock.
    Taccone FS; Brasseur A; Vincent JL; De Backer D
    Intensive Care Med; 2013 Aug; 39(8):1497-8. PubMed ID: 23673402
    [No Abstract]   [Full Text] [Related]  

  • 10. [Levosimendan for treatment of heart failure].
    Yasumura Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():169-72. PubMed ID: 17571380
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Creteur J; Bouckaert Y; Mélot C; Vincent JL
    Intensive Care Med; 2006 May; 32(5):790; author reply 791-2. PubMed ID: 16555067
    [No Abstract]   [Full Text] [Related]  

  • 12. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction.
    Missant C; Rex S; Segers P; Wouters PF
    Crit Care Med; 2007 Mar; 35(3):707-15. PubMed ID: 17255859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan in the treatment of cardiogenic shock.
    Buerkem B; Lemm H; Krohe K; Dietz S; Raaz U; Buerke U; Russ M; Schlitt A; Werdan K
    Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cardiogenic shock with the Ca2+ sensitizer levosimendan].
    Zobel C; Reuter H; Schwinger RH
    Med Klin (Munich); 2004 Dec; 99(12):742-6. PubMed ID: 15599685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of levosimendan in normodynamic endotoxaemia: a controlled experimental study.
    Dubin A; Maskin B; Murias G; Pozo MO; Sottile JP; Barán M; Edul VS; Canales HS; Estenssoro E
    Resuscitation; 2006 May; 69(2):277-86. PubMed ID: 16458408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K; Klocke RC; Schipke JD; Gams E; Korbmacher B
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
    Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
    Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].
    Mustapha F; Moufida H; Nedia B; Anis L; Iheb L; Habib H
    Tunis Med; 2005 Oct; 83(10):635-7. PubMed ID: 16370217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levosimendan].
    Michels G; Herzig S; Hoppe UC
    Dtsch Med Wochenschr; 2005 Oct; 130(43):2444-6. PubMed ID: 16240243
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Levosimendan on Endothelial Function and Hemodynamics During Weaning From Veno-Arterial Extracorporeal Life Support.
    Sangalli F; Avalli L; Laratta M; Formica F; Maggioni E; Caruso R; Cristina Costa M; Guazzi M; Fumagalli R
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1449-1453. PubMed ID: 27495966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.